trimethoprim has been researched along with Acantholysis Bullosa in 2 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuntz, HD | 1 |
| Erbs, G | 1 |
| Thiel, H | 1 |
| Müller, FE | 1 |
| May, B | 1 |
| Beyne, B | 1 |
2 other studies available for trimethoprim and Acantholysis Bullosa
| Article | Year |
|---|---|
[Hematologic and dermatologic side-effects of antibiotic therapy].
Topics: Aged; Agranulocytosis; Drug Combinations; Epidermolysis Bullosa; Female; Humans; Middle Aged; Sulfam | 1982 |
[Favorable effect of the sulfamethoxazole-trimethoprim combination on the evolution of congenital bullous epidermolysis of the dystrophic form].
Topics: Child, Preschool; Drug Combinations; Epidermolysis Bullosa; Humans; Male; Sulfamethoxazole; Trimetho | 1982 |